Your browser doesn't support javascript.
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351).
Salhotra, Amandeep; Aribi, Ahmed; Ngo, Dat; Zhang, Jianying; Sandhu, Karamjeet; Al-Malki, Monzr; Ali, Haris; Koller, Paul; Arslan, Shukaib; Budde, Elizabeth; Khaled, Samer; Dadwal, Sanjeet; Snyder, David S; Artz, Andrew; Forman, Stephen; Nakamura, Ryotaro; Stein, Anthony; Marcucci, Guido; Aldoss, Ibrahim; Pullarkat, Vinod.
  • Salhotra A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Aribi A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Ngo D; Department of Clinical Pharmacology, City of Hope National Medical Center, Duarte, California.
  • Zhang J; Department of Information Sciences, City of Hope National Medical Center, Duarte, California.
  • Sandhu K; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Al-Malki M; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Ali H; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Koller P; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Arslan S; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Budde E; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Khaled S; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Dadwal S; Division of Infectious Disease, City of Hope National Medical Center, Duarte, California.
  • Snyder DS; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Artz A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Forman S; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Nakamura R; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Stein A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Marcucci G; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Aldoss I; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Pullarkat V; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
Am J Hematol ; 96(6): E196-E200, 2021 06 01.
Article in English | MEDLINE | ID: covidwho-1445788
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Second Primary Type of study: Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Am J Hematol Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Second Primary Type of study: Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Am J Hematol Year: 2021 Document Type: Article